RNA Sequencing Reveals Transcriptional Signatures of Drug Response and SARS-CoV-2 Interaction in Colorectal Cancer Cells

this dataset contains the Illumina RNA-Seq raw and processed data (count matrix) from SW-480 colorectal cancer cells treated with cisplatin, Actemra (tocilizumab), and remdesivir, with and without SARS-CoV-2 infection. Data correspond to the analyses presented in the manuscript: RNA Sequencing Reveals Transcriptional Signatures of Drug Response and SARS-CoV-2 Interaction in Colorectal Cancer Cells本数据集包含经顺铂、托珠单抗（Actemra，通用名：tocilizumab）、瑞德西韦处理，且分别伴随或未伴随新型冠状病毒（SARS-CoV-2）感染的SW-480结直肠癌细胞的Illumina RNA测序（Illumina RNA-Seq）原始数据与处理后计数矩阵数据。本数据集对应学术论文《RNA测序揭示结直肠癌细胞中药物响应与新型冠状病毒互作的转录特征》中的分析内容。